FDA approves new treatment for adults with partial-onset seizures
(WorldNews Health)

SILVER SPRING, Md., Nov. 21, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults. `XCOPRI is a new option to treat adults with partial-onset seizures, which is an often difficult-to-control condition that can have a significant impact on patient quality of life,` said Billy Dunn, M.D., director of the Office of Neuroscience in the FDA`s Center for Drug Evaluation and Research. `Patients can have different responses to the various seizure medicines that are available. This approval provides an additional needed treatment option for people with this condition.` A seizure is a usually...